O-GlcNAc as a potential target for disease modifying therapy in Alzheimer disease

被引：0
|
作者：
Vocadlo, David J. [1 ,2 ]
Yuzwa, Scott A. [1 ]
Shan, Xiaoyang [2 ]
Heinonen, Julia [1 ]
Watson, Neil [3 ]
Jones, Bryan [3 ]
Macauley, Matthew S. [1 ]
Gong, Chengxin [4 ]
McEachern, Ernest [1 ]
Yadav, Anuj [1 ]
机构：
[1] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada
[2] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada
[3] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada
[4] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
215-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Tools, tactics and objectives to interrogate cellular roles of O-GlcNAc in disease
    Fehl, Charlie
    Hanover, John A.
    NATURE CHEMICAL BIOLOGY, 2022, 18 (01) : 8 - 17
  • [22] M1 Agonists as a Potential Disease-Modifying Therapy for Alzheimer's Disease
    Caccamo, Antonella
    Fisher, Abraham
    LaFerla, Frank M.
    CURRENT ALZHEIMER RESEARCH, 2009, 6 (02) : 112 - 117
  • [23] The potential role of O-GlcNAc modification in cancer epigenetics
    Ewa Forma
    Paweł Jóźwiak
    Magdalena Bryś
    Anna Krześlak
    Cellular & Molecular Biology Letters, 2014, 19 : 438 - 460
  • [24] The potential role of O-GlcNAc modification in cancer epigenetics
    Forma, Ewa
    Jozwiak, Pawel
    Brys, Magdalena
    Krzeslak, Anna
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2014, 19 (03) : 438 - 460
  • [25] O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy
    Dong, Wenkang
    Imdad, Laraib
    Xu, Shengnan
    Wang, Yinli
    Liu, Chengzhi
    Song, Shiyu
    Li, Zechuan
    Kong, Ying
    Kong, Li
    Ren, Xiang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [26] PROJECTING THE POTENTIAL IMPACT OF DISEASE MODIFYING THERAPY ON THE FUTURE HEALTH AND SOCIAL COSTS OF ALZHEIMER'S DISEASE
    Trepel, D.
    Edwards, S.
    Ritchie, C.
    Hahn-Pedersen, J. H.
    Kettle, J.
    Chan, M. S.
    Bray, B. D.
    Clark, A.
    Ivkovic, M.
    Wichmann, C. A.
    Evans, L. M.
    VALUE IN HEALTH, 2023, 26 (12) : S406 - S406
  • [27] Writing and erasing O-GlcNAc from target proteins in cells
    Ge, Yun
    Woo, Christina M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2021, 49 (06) : 2891 - 2901
  • [28] O-GlcNAc Regulation of Autophagy and α-synuclein Homeostasis; Implications for Parkinson's Disease
    Wani, Willayat Y.
    Ouyang, Xiaosen
    Benavides, Gloria A.
    Redmann, Matthew
    Cofield, Stacey S.
    Shacka, John J.
    Chatham, John C.
    Darley-Usmar, Victor
    Zhang, Jianhua
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 112 : 179 - 180
  • [29] O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease
    Ryan, Philip
    Xu, Mingming
    Davey, Andrew K.
    Danon, Jonathan J.
    Mellick, George D.
    Kassiou, Michael
    Rudrawar, Santosh
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (05): : 2209 - 2221
  • [30] O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson's disease
    Wani, Willayat Y.
    Ouyang, Xiaosen
    Benavides, Gloria A.
    Redmann, Matthew
    Cofield, Stacey S.
    Shacka, John J.
    Chatham, John C.
    Darley-Usmar, Victor
    Zhang, Jianhua
    MOLECULAR BRAIN, 2017, 10
12345